Novus Therapeutics, Inc.

/Novus Therapeutics, Inc.

Secondary offering. Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for disorders of the ear, nose, and throat (“ENT”).

Symbol

Last Closing Price
$5.42

Shares
TBD

Anticipated Date
TBD

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange